Torrent Pharma Shareholders Approve Amalgamation with J.B. Chemicals

Torrent Pharmaceuticals Ltd ( (IN:TORNTPHARM) ) has issued an update.

Torrent Pharmaceuticals Ltd. has disclosed the voting results of its National Company Law Tribunal-convened meeting of equity shareholders held on April 28, 2026, conducted via video conferencing and other audio-visual means. The meeting was called to consider a Scheme of Amalgamation involving J. B. Chemicals & Pharmaceuticals Ltd. as the transferor company and Torrent Pharma as the transferee company.

Equity shareholders approved the amalgamation by the requisite majority, defined as a majority in number representing three-fourths in value, clearing a key corporate governance hurdle for the proposed merger. Voting was carried out through remote e-voting, with both promoter and public shareholders participating, signaling broad shareholder support and paving the way for further regulatory and implementation steps in consolidating the two pharmaceutical businesses.

More about Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd. is an Indian pharmaceutical company engaged in the development, manufacture and marketing of branded and generic formulations. The company focuses on key therapeutic areas including cardiovascular, central nervous system, gastro-intestinal, and other chronic and acute segments, serving both domestic and international markets.

Average Trading Volume: 13,914

Technical Sentiment Signal: Buy

Current Market Cap: 1392.9B INR

For detailed information about TORNTPHARM stock, go to TipRanks’ Stock Analysis page.